Medicamen Organics Limited (NSE:MEDIORG)
India
· Delayed Price · Currency is INR 29.25
-0.80 (-2.66%)
Apr 29, 2026, 3:25 PM IST
Medicamen Organics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Net Income | 45.74 | 40.47 | 26.24 | 9.69 | 1.01 | 2.44 | Upgrade
|
| Depreciation & Amortization | 3.79 | 5.97 | 7.19 | 7.12 | 6.8 | 7.84 | Upgrade
|
| Other Operating Activities | 24.84 | 17.08 | 12.18 | 1.63 | 4.08 | 4.83 | Upgrade
|
| Change in Accounts Receivable | -79.15 | -91.52 | -59.32 | -45.23 | 12.84 | -20.07 | Upgrade
|
| Change in Inventory | -16.02 | -13.47 | -0.04 | -14.17 | -20.61 | 17.04 | Upgrade
|
| Change in Accounts Payable | 13.61 | 46.23 | -19.19 | 24.81 | 4.81 | -21.5 | Upgrade
|
| Change in Other Net Operating Assets | 11.09 | -50.2 | -3.69 | 10.32 | -8.56 | -3.01 | Upgrade
|
| Operating Cash Flow | 3.9 | -45.43 | -36.62 | -5.84 | 0.37 | -12.43 | Upgrade
|
| Capital Expenditures | -29.87 | -24.47 | -3.51 | -2.89 | -6.16 | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.35 | Upgrade
|
| Other Investing Activities | 0.68 | 0.95 | 0.13 | 0.08 | 0.23 | 0.12 | Upgrade
|
| Investing Cash Flow | -29.2 | -23.53 | -3.37 | -2.81 | -5.93 | 0.48 | Upgrade
|
| Short-Term Debt Issued | - | - | 12.54 | - | - | 10.26 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 15.49 | 6.56 | 7.08 | Upgrade
|
| Total Debt Issued | 30.96 | - | 12.54 | 15.49 | 6.56 | 17.34 | Upgrade
|
| Short-Term Debt Repaid | - | -3 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.04 | -3.93 | - | - | - | Upgrade
|
| Total Debt Repaid | -3.03 | -3.03 | -3.93 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 27.92 | -3.03 | 8.62 | 15.49 | 6.56 | 17.34 | Upgrade
|
| Issuance of Common Stock | - | 105.4 | 38 | - | - | - | Upgrade
|
| Other Financing Activities | 6.25 | 2.36 | -6.47 | -6.12 | -4.73 | -4.43 | Upgrade
|
| Financing Cash Flow | 34.17 | 104.73 | 40.14 | 9.37 | 1.83 | 12.91 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | 8.87 | 35.77 | 0.15 | 0.72 | -3.73 | 0.96 | Upgrade
|
| Free Cash Flow | -25.97 | -69.9 | -40.13 | -8.73 | -5.79 | -12.43 | Upgrade
|
| Free Cash Flow Margin | -6.59% | -18.30% | -15.88% | -3.94% | -2.76% | -4.96% | Upgrade
|
| Free Cash Flow Per Share | -2.18 | -6.32 | -5.31 | -1.46 | -0.96 | -2.07 | Upgrade
|
| Cash Interest Paid | 6.26 | 5.14 | 6.47 | 5.66 | 4.36 | 4.43 | Upgrade
|
| Cash Income Tax Paid | - | 0.94 | 1.81 | 0.48 | 0.65 | - | Upgrade
|
| Levered Free Cash Flow | -64.39 | -72.1 | -52.37 | -20.54 | -10.79 | -14.18 | Upgrade
|
| Unlevered Free Cash Flow | -60.69 | -69.11 | -48.47 | -17.01 | -8.07 | -11.41 | Upgrade
|
| Change in Working Capital | -70.48 | -108.95 | -82.23 | -24.27 | -11.52 | -27.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.